Abstract

In Kampo medicine, two different formulas are effective for treating dysmenorrhea—tokishakuyakusan and keishibukuryogan; however, the criteria by which specialists select the appropriate formula for each patient are not clear. We compared patients treated with tokishakuyakusan and those with keishibukuryogan and proposed a predictive model. The study included 168 primary and secondary dysmenorrhea patients who visited the Kampo Clinic at Keio University Hospital. We collected clinical data from 128 dysmenorrhea patients, compared the two patient groups and selected significantly different factors as potential predictors, and used logistic regression to establish a model. An external validation was performed using 40 dysmenorrhea patients. Lightheadedness, BMI < 18.5, and a weak abdomen were significantly more frequent in the tokishakuyakusan group; tendency to sweat, heat intolerance, leg numbness, a cold sensation in the lower back, a strong abdomen, and paraumbilical tenderness and resistance were more frequent in the keishibukuryogan group. The final model fitted the data well. Internally estimated accuracy was 81.2%, and a leave-one-out cross-validation estimate of accuracy was 80.5%. External validation accuracy was 85.0%. We proposed a model for predicting the use of two Kampo formulas for dysmenorrhea, which should be validated in prospective trials.

Highlights

  • Dysmenorrhea is the most common gynecological disorder in women, regardless of age and nationality [1]

  • nonsteroidal anti-inflammatory drugs (NSAIDs) are contraindicated in patients with a peptic ulcer or gastritis

  • We assessed the eligibility of 290 dysmenorrhea patients—222 patients for the comparison and model-development analysis and 68 patients for the external validation analysis

Read more

Summary

Introduction

Dysmenorrhea is the most common gynecological disorder in women, regardless of age and nationality [1]. Patients with dysmenorrhea have strong lower abdominal or lower back pain that begins during or just before the menstrual period. Pain is induced by uterine hypercontractility, reduced uterine blood flow, and increased peripheral nerve hypersensitivity [2]. The standard treatment for dysmenorrhea is nonsteroidal anti-inflammatory drugs (NSAIDs) or oral contraceptives (OCs) [3, 4]. Up to 30% of patients, do not respond sufficiently to NSAIDs, and 10% to 20% respond to neither NSAIDs nor OCs [1]. NSAIDs are contraindicated in patients with a peptic ulcer or gastritis. OCs are contraindicated in those with any thrombotic predisposing factor, breast cancer, migraine with aura, or pregnancy. For these reasons, various alternative treatments have been

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call